XML 15 R6.htm IDEA: XBRL DOCUMENT v3.23.2
CONSOLIDATED STATEMENT OF SHAREHOLDERS EQUITY - USD ($)
$ in Millions
Total
Common stock
Capital in excess of par value
Retained earnings
Accumulated  other comprehensive (loss) income
Treasury stock
Non-controlling interest
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Treasury stock (in shares)           21,152,645  
Common stock outstanding, beginning balance, shares at Dec. 31, 2021   275,726,629          
Beginning Balance at Dec. 31, 2021 $ 21,117 $ 35 $ 19,826 $ 3,641 $ (1,423) $ (997) $ 35
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income (loss) 353     351     2
Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax 1       1    
Cash dividends declared (403)     (403)      
Stock Issued During Period, Value, Stock Options Exercised 14   10     $ 4  
Stock options/SSARs, shares           84,177  
Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures (25)   (38)     $ 13  
Vested restricted stock units and awards, shares           286,570  
APIC, Share-Based Payment Arrangement, Increase for Cost Recognition 25   25        
Exercises of redeemable noncontrolling interests 5   (1)       6
Net Income (Loss) Attributable to Redeemable Noncontrolling Interest 2   2        
Dividends paid 2           2
Common stock outstanding, ending balance, shares at Jun. 30, 2022   275,726,629          
Ending Balance at Jun. 30, 2022 20,293 $ 35 19,826 3,589 (2,210) $ (980) 33
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Foreign currency translation adjustments (788)       (788)    
Treasury stock (in shares)           20,921,882  
Common stock outstanding, beginning balance, shares at Mar. 31, 2022   275,726,629          
Beginning Balance at Mar. 31, 2022 20,965 $ 35 19,823 3,683 (1,622) $ (986) 32
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income (loss) 107     107      
Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax 1       1    
Cash dividends declared (201)     (201)      
Stock Issued During Period, Value, Stock Options Exercised 1   1        
Stock options/SSARs, shares           4,024  
Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures (10)   (16)     $ 6  
Vested restricted stock units and awards, shares           135,960  
APIC, Share-Based Payment Arrangement, Increase for Cost Recognition 16   16        
Exercises of redeemable noncontrolling interests 1           1
Net Income (Loss) Attributable to Redeemable Noncontrolling Interest 2   2        
Dividends paid 2           2
Common stock outstanding, ending balance, shares at Jun. 30, 2022   275,726,629          
Ending Balance at Jun. 30, 2022 20,293 $ 35 19,826 3,589 (2,210) $ (980) 33
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Foreign currency translation adjustments $ (589)       (589)    
Treasury stock (in shares)           20,781,898  
Treasury stock (in shares) 20,758,166         20,758,166  
Common stock outstanding, beginning balance, shares at Dec. 31, 2022   275,726,629          
Beginning Balance at Dec. 31, 2022 $ 17,685 $ 35 19,841 955 (2,198) $ (978) 30
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income (loss) 19     18     1
Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax (3)       (3)    
Cash dividends declared (413)     (413)      
Stock Issued During Period, Value, Stock Options Exercised 0   (3)     $ 3  
Stock options/SSARs, shares           58,886  
Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures (9)   (18)     $ 9  
Vested restricted stock units and awards, shares           194,382  
APIC, Share-Based Payment Arrangement, Increase for Cost Recognition 32   32        
Net Income (Loss) Attributable to Redeemable Noncontrolling Interest (1)   (1)        
Dividends paid 1           1
Common stock outstanding, ending balance, shares at Jun. 30, 2023   275,726,629          
Ending Balance at Jun. 30, 2023 17,655 $ 35 19,851 560 (1,857) $ (966) 32
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Foreign currency translation adjustments 344       344    
Treasury stock (in shares)           20,659,153  
Common stock outstanding, beginning balance, shares at Mar. 31, 2023   275,726,629          
Beginning Balance at Mar. 31, 2023 17,761 $ 35 19,844 739 (1,916) $ (973) 32
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income (loss) 27     27      
Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax (1)       (1)    
Cash dividends declared (206)     (206)      
Stock Issued During Period, Value, Stock Options Exercised 2   2        
Stock options/SSARs, shares           3,269  
Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures (7)   (14)     $ 7  
Vested restricted stock units and awards, shares           150,986  
APIC, Share-Based Payment Arrangement, Increase for Cost Recognition 20   20        
Net Income (Loss) Attributable to Redeemable Noncontrolling Interest 1   1        
Common stock outstanding, ending balance, shares at Jun. 30, 2023   275,726,629          
Ending Balance at Jun. 30, 2023 17,655 $ 35 $ 19,851 $ 560 (1,857) $ (966) $ 32
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Foreign currency translation adjustments $ 60       $ 60    
Treasury stock (in shares) 20,504,898         20,504,898